Removal of medicaid restrictions were associated with increased hepatitis C virus treatment rates, but disparities persist

Despite the release of a growing number of direct‐acting antivirals and evolving policy landscape, many of those diagnosed with hepatitis C virus (HCV) have not received treatment. Those from vulnerable populations are at particular risk of being unable to access treatment, threatening World Health...

Ausführliche Beschreibung